SCHEMBL20161474

SCHEMBL20161474

CC[C@H]1CN(C)CCCN1C

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20161410 1.00 CYP1A2 (0.35) CYP1A2
SCHEMBL16707752 1.00 CYP1A2 (0.35) CYP1A2
SCHEMBL14948548 0.86 KAT6A (0.32)
SCHEMBL14948558 0.86 KAT6A (0.32)
SCHEMBL90077 0.86 KAT6A (0.32)
SCHEMBL2048600 0.84 NCF1 (0.34)
SCHEMBL23366040 0.78 ALDH1A1 (0.33)
SCHEMBL19334280 0.78 CYP1A2 (0.33) CYP1A2
SCHEMBL23366044 0.75 CYP1A2 (0.32) CYP1A2
SCHEMBL23366003 0.75 PKM (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3534899-B1 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS INC (US) 2022-06-01 EP disclosed
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed